Financials Jianzhijia Pharmaceutical Chain Group Co., Ltd.

Equities

605266

CNE100004JG5

Drug Retailers

End-of-day quote Shanghai S.E. 23:00:00 25/06/2024 BST 5-day change 1st Jan Change
27.95 CNY +0.79% Intraday chart for Jianzhijia Pharmaceutical Chain Group Co., Ltd. -8.66% -43.54%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,889 5,324 7,940 7,654 4,322 - -
Enterprise Value (EV) 1 5,889 5,324 7,940 7,654 4,322 4,322 4,322
P/E ratio 18.1 x 17.6 x 21.2 x 18.4 x 9.39 x 7.2 x 6.32 x
Yield - - - 2.16% 3.85% 4.68% 5.72%
Capitalization / Revenue 1.32 x - - 0.84 x 0.4 x 0.31 x 0.27 x
EV / Revenue 1.32 x - - 0.84 x 0.4 x 0.31 x 0.27 x
EV / EBITDA 16.3 x - - 10.6 x 4.44 x 3.71 x 3.11 x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book 3.43 x - - 2.68 x 1.37 x 1.21 x 1.09 x
Nbr of stocks (in thousands) 139,729 140,998 154,694 154,619 154,619 - -
Reference price 2 42.15 37.76 51.33 49.50 27.95 27.95 27.95
Announcement Date 14/04/21 27/04/22 26/04/23 26/04/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,466 - - 9,081 10,768 13,920 15,719
EBITDA 1 361 - - 719.7 973.5 1,165 1,392
EBIT 1 292.3 - - 522.1 568.9 741.6 871.4
Operating Margin 6.54% - - 5.75% 5.28% 5.33% 5.54%
Earnings before Tax (EBT) 1 300.5 - - 522.7 608.9 761.1 911.4
Net income 1 251.1 300.5 363.4 414.4 460.2 601 684.7
Net margin 5.62% - - 4.56% 4.27% 4.32% 4.36%
EPS 2 2.333 2.150 2.417 2.683 2.975 3.883 4.425
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - 1.071 1.075 1.308 1.600
Announcement Date 14/04/21 27/04/22 26/04/23 26/04/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) 31.8% - - 15.2% 14.6% 16.8% 17.3%
ROA (Net income/ Total Assets) - - - 4.23% 6.26% 6.68% 7.06%
Assets 1 - - - 9,797 7,351 8,997 9,699
Book Value Per Share 2 12.30 - - 18.50 20.40 23.10 25.50
Cash Flow per Share 2 2.270 - - 6.630 7.440 6.940 8.100
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 14/04/21 27/04/22 26/04/23 26/04/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
27.95 CNY
Average target price
52.06 CNY
Spread / Average Target
+86.27%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 605266 Stock
  4. Financials Jianzhijia Pharmaceutical Chain Group Co., Ltd.